Cargando…

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder

BACKGROUND: Social functioning (SF), the ability to engage with life and fulfill roles may be a salient “patient important outcome” in addiction treatment. It is not known if medication-assisted treatment (MAT) impacts SF in opioid use disorder (OUD). There is a growing evidence to suggest that men...

Descripción completa

Detalles Bibliográficos
Autores principales: van Reekum, Emma A., Rosic, Tea, Hudson, Jacqueline, Sanger, Nitika, Marsh, David C., Worster, Andrew, Thabane, Lehana, Samaan, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181574/
https://www.ncbi.nlm.nih.gov/pubmed/32326982
http://dx.doi.org/10.1186/s13293-020-00298-4
_version_ 1783526068499513344
author van Reekum, Emma A.
Rosic, Tea
Hudson, Jacqueline
Sanger, Nitika
Marsh, David C.
Worster, Andrew
Thabane, Lehana
Samaan, Zainab
author_facet van Reekum, Emma A.
Rosic, Tea
Hudson, Jacqueline
Sanger, Nitika
Marsh, David C.
Worster, Andrew
Thabane, Lehana
Samaan, Zainab
author_sort van Reekum, Emma A.
collection PubMed
description BACKGROUND: Social functioning (SF), the ability to engage with life and fulfill roles may be a salient “patient important outcome” in addiction treatment. It is not known if medication-assisted treatment (MAT) impacts SF in opioid use disorder (OUD). There is a growing evidence to suggest that men and women are impacted differently by OUD. This study is the largest to date to study sex differences in OUD and explore associations between MAT and SF. METHODS: Data were collected from 2736 participants with OUD, enrolled in MAT for varying lengths of time, in outpatient clinics across Ontario. SF was defined according to the Maudsley Addiction Profile’s domains of (1) employment, (2) criminal activity, and (3) interpersonal conflict. Using logistic regression analysis, we examined sociodemographic and clinical factors associated with domains of SF. RESULTS: There were 1544 men (56%) and 1192 women (44%) in this study, and ages varied from 17 to 76 years for men and 18 to 69 years for women. At study entry, participants had been on MAT for a median of 2 years. Compared to men, women reported more psychological (mean MAP score 14/40, SD = 9.55, versus 11/40, SD = 8.64; p < 0.001) and physical symptoms (mean MAP score 17/40, SD = 7.70 versus 14/40, SD = 7.74; p < 0.001). More women reported unemployment(74% versus 58%; p < 0.0001) and interpersonal conflict (46% versus 35%; p < 0.0001). Men were more likely than women to report criminal activity (11%, versus 8%; p = 0.001). Psychological symptoms increased the risk of worse SF, across domains, for men and for women. Every year on MAT was associated with a 7% increase in the odds of women engaging with criminal activity (OR = 1.07, 95% CI 1.02, 1.12, p = 0.006). CONCLUSIONS: Men and women had different SF profiles and psychological symptoms scores while on MAT. The length of time on MAT increased the risk of criminal activity in women, and overall, duration of MAT was not associated with improvement in SF. This may suggest that MAT alone may not support continual improvements in SF in OUD.
format Online
Article
Text
id pubmed-7181574
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71815742020-04-28 Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder van Reekum, Emma A. Rosic, Tea Hudson, Jacqueline Sanger, Nitika Marsh, David C. Worster, Andrew Thabane, Lehana Samaan, Zainab Biol Sex Differ Research BACKGROUND: Social functioning (SF), the ability to engage with life and fulfill roles may be a salient “patient important outcome” in addiction treatment. It is not known if medication-assisted treatment (MAT) impacts SF in opioid use disorder (OUD). There is a growing evidence to suggest that men and women are impacted differently by OUD. This study is the largest to date to study sex differences in OUD and explore associations between MAT and SF. METHODS: Data were collected from 2736 participants with OUD, enrolled in MAT for varying lengths of time, in outpatient clinics across Ontario. SF was defined according to the Maudsley Addiction Profile’s domains of (1) employment, (2) criminal activity, and (3) interpersonal conflict. Using logistic regression analysis, we examined sociodemographic and clinical factors associated with domains of SF. RESULTS: There were 1544 men (56%) and 1192 women (44%) in this study, and ages varied from 17 to 76 years for men and 18 to 69 years for women. At study entry, participants had been on MAT for a median of 2 years. Compared to men, women reported more psychological (mean MAP score 14/40, SD = 9.55, versus 11/40, SD = 8.64; p < 0.001) and physical symptoms (mean MAP score 17/40, SD = 7.70 versus 14/40, SD = 7.74; p < 0.001). More women reported unemployment(74% versus 58%; p < 0.0001) and interpersonal conflict (46% versus 35%; p < 0.0001). Men were more likely than women to report criminal activity (11%, versus 8%; p = 0.001). Psychological symptoms increased the risk of worse SF, across domains, for men and for women. Every year on MAT was associated with a 7% increase in the odds of women engaging with criminal activity (OR = 1.07, 95% CI 1.02, 1.12, p = 0.006). CONCLUSIONS: Men and women had different SF profiles and psychological symptoms scores while on MAT. The length of time on MAT increased the risk of criminal activity in women, and overall, duration of MAT was not associated with improvement in SF. This may suggest that MAT alone may not support continual improvements in SF in OUD. BioMed Central 2020-04-23 /pmc/articles/PMC7181574/ /pubmed/32326982 http://dx.doi.org/10.1186/s13293-020-00298-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
van Reekum, Emma A.
Rosic, Tea
Hudson, Jacqueline
Sanger, Nitika
Marsh, David C.
Worster, Andrew
Thabane, Lehana
Samaan, Zainab
Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title_full Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title_fullStr Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title_full_unstemmed Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title_short Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
title_sort social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181574/
https://www.ncbi.nlm.nih.gov/pubmed/32326982
http://dx.doi.org/10.1186/s13293-020-00298-4
work_keys_str_mv AT vanreekumemmaa socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT rosictea socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT hudsonjacqueline socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT sangernitika socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT marshdavidc socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT worsterandrew socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT thabanelehana socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder
AT samaanzainab socialfunctioningoutcomesinmenandwomenreceivingmedicationassistedtreatmentforopioidusedisorder